Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Abbott will add a new FDA-cleared molecular diagnostic test for detection and differentiation of influenza A and B and respiratory syncytial virus to its infectious disease testing menu. The IMDx Flu A/B and RSV test developed by IntelligentMDx (IMDx) of Cambridge, Mass., is performed on Abbott’s m2000 molecular diagnostics system.
The Clinical and Laboratory Standards Institute has released an updated edition of its standard NBS01-A6 (replaces LA04-A5), “Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard-Sixth Edition.” This document contains new information and insight for personnel on the essentials of correctly collecting a high-quality specimen, handling the specimen after it has been collected, transporting it to the testing facility, and sorting the residual specimen that remains after laboratory testing.
Diagnostic BioSystems added a new chromogen to its color spectrum—PermaBlack/HRP. This HRP-based substrate/chromogen system produces a sharply contrasting ebony black stain, which serves as a useful tool in immunohistochemical and in situ hybridization staining procedures.
September 2013—Life Technologies and RainTree Oncology Services have entered into a collaborative agreement designed to further the advancement of personalized care for cancer patients.
Seegene has entered into a collaborative agreement with Eidia, the in vitro diagnostics subsidiary arm of Eisai Co., headquartered in Japan. Through this agreement, Eidia gains access to Seegene’s portfolio of Toce technology-based multiplex molecular diagnostic tests for the Japanese diagnostic test market.
The CHU de Québec, a health care institution in Québec, and Copan Diagnostics announced the full installation of the WASPLab laboratory automation and digital microbiology system in Hôpital de l’Enfant-Jésus, one of the five hospitals forming the CHU de Québec.
Horizon Diagnostics has signed a distribution agreement with Riken Genesis under which Riken will become the sole distributor of HDx’s molecular reference standards in Japan. Riken Genesis offers genomic products and services to a range of research institutions and corporations and is a CAP-accredited laboratory for genome analysis services.
SeraCare Life Sciences has introduced a new AccuSet anti-Toxoplasma performance panel.
BioFire Diagnostics has begun clinical and analytical studies at several hospital-based laboratories in the U.S. to evaluate the company’s FilmArray gastrointestinal panel. BioFire plans to seek CE IVD marking and FDA clearance for the test.
ELITechGroup Biomedical Systems has launched a new Series 2 generation of Aerospray slide stainers. The stainers have large touchscreens, bar-code readers, and intuitive user interfaces with language selection and help screens.
